Unknown

Dataset Information

0

Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection.


ABSTRACT: Hepatitis A virus (HAV) infection typically resolves within 4-7 wk but symptomatic relapse occurs in up to 20% of cases. Immune mechanisms that terminate acute HAV infection, and prevent a relapse of virus replication and liver disease, are unknown. Here, patterns of T cell immunity, virus replication, and hepatocellular injury were studied in two HAV-infected chimpanzees. HAV-specific CD8(+) T cells were either not detected in the blood or failed to display effector function until after viremia and hepatitis began to subside. The function of CD8(+) T cells improved slowly as the cells acquired a memory phenotype but was largely restricted to production of IFN-?. In contrast, CD4(+) T cells produced multiple cytokines when viremia first declined. Moreover, only CD4(+) T cells responded during a transient resurgence of fecal HAV shedding. This helper response then contracted slowly over several months as HAV genomes were eliminated from liver. The findings indicate a dominant role for CD4(+) T cells in the termination of HAV infection and, possibly, surveillance of an intrahepatic reservoir of HAV genomes that decays slowly. Rapid contraction or failure to sustain such a CD4(+) T cell response after resolution of symptoms could increase the risk of relapsing hepatitis A.

SUBMITTER: Zhou Y 

PROVIDER: S-EPMC3409494 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection.

Zhou Yan Y   Callendret Benoît B   Xu Dan D   Brasky Kathleen M KM   Feng Zongdi Z   Hensley Lucinda L LL   Guedj Jeremie J   Perelson Alan S AS   Lemon Stanley M SM   Lanford Robert E RE   Walker Christopher M CM  

The Journal of experimental medicine 20120702 8


Hepatitis A virus (HAV) infection typically resolves within 4-7 wk but symptomatic relapse occurs in up to 20% of cases. Immune mechanisms that terminate acute HAV infection, and prevent a relapse of virus replication and liver disease, are unknown. Here, patterns of T cell immunity, virus replication, and hepatocellular injury were studied in two HAV-infected chimpanzees. HAV-specific CD8(+) T cells were either not detected in the blood or failed to display effector function until after viremia  ...[more]

Similar Datasets

| S-EPMC3428091 | biostudies-literature
| S-EPMC6927865 | biostudies-literature
| S-EPMC1316027 | biostudies-literature
| S-EPMC1933276 | biostudies-literature
| S-EPMC2888096 | biostudies-literature
| S-EPMC3052717 | biostudies-literature
| S-EPMC4276420 | biostudies-literature
| S-EPMC3624224 | biostudies-literature
| S-EPMC5989350 | biostudies-literature
| S-EPMC2956746 | biostudies-literature